Internal Medicine, Hematology & Oncology · Weatherford, TX
NPI
1669422143
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
920 Santa Fe Dr
Weatherford, TX, 76086
Phone (817) 759-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
199,113 services
Medicare patients, 2024
433
Average age 76
Drug cost, 2024
$4.6M
1,167 prescriptions
Company payments, 2025
$3,275
From 51 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ray Page was code J1439 (injection, ferric carboxymaltose, 1 mg), 53,250 times for 36 patients. In total Ray Page billed 199,113 services in 163 codes, and Medicare paid $3.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 53,250 | 36 | $0.87 | $46K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 20,250 | 28 | $0.11 | $2,273 |
| J0897 Injection, denosumab, 1 mg | Office | 3,700 | 26 | $20.69 | $77K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,616 | 38 | $0.09 | $235 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,670 | 31 | $0.67 | $1,121 |
| 99214 Office E&M - Established | Office | 769 | 285 | $91.00 | $70K |
| 96375 Injection Administration | Office | 487 | 49 | $11.46 | $5,581 |
| 96413 Chemotherapy Administration | Office | 455 | 57 | $94.42 | $43K |
| 99215 Office E&M - Established | Office | 360 | 122 | $135.37 | $49K |
| 96367 Intravenous Infusion, Hydration | Office | 319 | 46 | $21.14 | $6,745 |
| 96372 Injection Administration | Office | 313 | 65 | $10.44 | $3,268 |
| J3315 Injection, triptorelin pamoate, 3.75 mg | Office | 228 | 24 | $341.55 | $78K |
| 96365 Intravenous Infusion, Hydration | Office | 211 | 77 | $45.81 | $9,665 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 209 | 31 | $4.98 | $1,042 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 176 | 30 | $0.65 | $115 |
By year: 2022 $3.0M for 197,262 services; 2023 $2.5M for 194,933 services; 2024 $3.2M for 199,113 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 20 | 19 | $8.65 | $173 |
| 80053 Clinical Chemistry | 11 | 11 | $10.35 | $114 |
Medicare prescription drug claims, 2024
In 2024, the drug Ray Page prescribed most often to Medicare patients was Anastrozole, with 141 prescriptions and refills. In total Ray Page wrote 1,167 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 141 | 290 | 31 | $1,809 |
| Prednisone Generic | 67 | 67 | Under 11 | $219 |
| Ondansetron Odt Ondansetron | 53 | 53 | 34 | $636 |
| Abiraterone Acetate Generic | 48 | 50 | Under 11 | $69K |
| Gabapentin Generic | 44 | 66 | 11 | $332 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 42 | 42 | 17 | $1,544 |
| Imbruvica Ibrutinib | 40 | 40 | Under 11 | $482K |
| Prochlorperazine Maleate Generic | 40 | 40 | 26 | $462 |
| Revlimid Lenalidomide | 39 | 39 | Under 11 | $621K |
| Imatinib Mesylate Generic | 34 | 34 | Under 11 | $104K |
| Eliquis Apixaban | 29 | 55 | Under 11 | $29K |
| Erleada Apalutamide | 29 | 29 | Under 11 | $432K |
| Bicalutamide Generic | 29 | 41 | Under 11 | $493 |
| Lonsurf Trifluridine/Tipiracil Hcl | 26 | 26 | Under 11 | $426K |
| Lenalidomide Generic | 24 | 24 | Under 11 | $359K |
Brand drugs: 322 claims; generic drugs: 845 claims; opioid claims: 83.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ray Page $3,275 ($3,275 in general payments such as food, travel and fees) from 51 companies. The largest payer was Incyte Corporation with $220.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.